Gain Therapeutics, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
---|---|---|---|---|
![]() BIVI
BioVie Inc. |
$1.08 | $19.76 M | -0.33 | 14 |
![]() MACK
Merrimack Pharmaceuticals, Inc. |
$15.15 | $223.97 M | -168.28 | 0 |
![]() CELC
Celcuity Inc. |
$10.18 | $384.45 M | -3.59 | 87 |
![]() LIFE
aTyr Pharma, Inc. |
$1.90 | $131.12 M | -2.16 | 56 |
![]() INBX
Inhibrx Biosciences, Inc. |
$11.10 | $159.67 M | 0.1 | 156 |
![]() ELVN
Enliven Therapeutics, Inc. |
$18.27 | $896.78 M | -9.68 | 62 |
![]() MNOV
MediciNova, Inc. |
$1.49 | $75.04 M | -6.65 | 13 |
![]() NAMS
NewAmsterdam Pharma Company N.V. |
$18.92 | $2.12 B | -7.4 | 68 |
![]() CUE
Cue Biopharma, Inc. |
$0.77 | $57.35 M | -1.06 | 41 |
![]() CYT
Cyteir Therapeutics, Inc. |
$3.02 | $108.71 M | -3.25 | 46 |
![]() LTRN
Lantern Pharma Inc. |
$4.34 | $47.13 M | -2.26 | 24 |
![]() TFFP
TFF Pharmaceuticals, Inc. |
$0.07 | $288.80 K | -0.01 | 19 |
![]() INAB
IN8bio, Inc. |
$0.16 | $13.24 M | -0.29 | 18 |
![]() ELYM
Eliem Therapeutics, Inc. |
$5.11 | $342.68 M | -2.3 | 9 |
![]() ANEB
Anebulo Pharmaceuticals, Inc. |
$1.09 | $43.96 M | -3.69 | 2 |
![]() CSBR
Champions Oncology, Inc. |
$5.81 | $79.92 M | 12.84 | 210 |
![]() MOLN
Molecular Partners AG |
$4.05 | $153.40 M | -2.17 | 158 |